• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALMA LASERS LTD HARMONY XL PRO DYE-VL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALMA LASERS LTD HARMONY XL PRO DYE-VL Back to Search Results
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Code Scar Tissue (2060)
Date of Event 02/13/2024
Type of Reportable Event Serious Injury
Event or Problem Description
Burn/scar on right cheek.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HARMONY XL PRO DYE-VL
Common Device Name
HARMONY XL PRO DYE-VL
Manufacturer (Section D)
ALMA LASERS LTD
18 haharash street
north industrial park
caesarea, 30798 95
IS  3079895
MDR Report Key18859379
Report Number3004450661-2024-00006
Device Sequence Number16348198
Product Code GEX
Combination Product (Y/N)N
Initial Reporter StateWA
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Importer
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 03/07/2024
Report Date (Section F) 03/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date02/15/2024
Event Location Outpatient Treatment Facility
Date Report to Manufacturer03/07/2024
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date03/07/2024
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexFemale
Date Report Sent to FDA03/07/2024
-
-